Genetic influence on early onset Alzeimer's disease

6Citations
Citations of this article
46Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: Early onset Alzheimeŕs disease (EOAD) represents 5% of all cases of Alzheimeŕs disease, and it is connected to genic mutations. Objectives: To present the influence of genic mutations in EOAD. Methods: Review of current literature, starting from 1992, utilizing the PubMed data bank. Results: The E4 allele of the apolipoprotein E gene interferes in EOAD. In the gene of the Amyloid Precursor Protein, 20 mutations were described, causing 10% to 15% of the cases of EOAD. Mutations in the gene of presenilins 1 and 2 cause 30% to 70% of the cases of EOAD. In PSN1 gene, 30 aminoacid change mutations and 3 insertions/deletions are known. In the PSEN2 gene, there are 6 aminoacid change mutations. Only one mutation in the MAPT gene is selectively associated with Alzheimer's disease. Conclusions: The use of genetic information for early detection of possible pacients of EOAD is still very limited. Genetic heterogeneity is broad. Some mutations described in this review were responsible for Alzheimer's disease only in a few families. The clinical utilization of these methods for screening individuals at risk for EOAD still asks for caution.

Cite

CITATION STYLE

APA

Lucatelli, J. F., Barros, A. C., Sharbel, M. W., & De Andrade, F. M. (2009). Genetic influence on early onset Alzeimer’s disease. Revista de Psiquiatria Clinica, 36(1), 25–30. https://doi.org/10.1590/s0101-60832009000100004

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free